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ABSTRACT  
Genetic factors may interact with lifestyle factors to modify obesity risk. FTO and 
PPARG2 are relevant obesogenes. Our aim was to explore the effect of Pro12Ala 
(rs1801282) of PPARG2 and rs9939609 of FTO, on obesity risk and to examine their 
interaction with lifestyle factors in an elderly population. 
Subjects (n=978, aged 69±6) were recruited from the SUN (“Seguimiento Universidad 
de Navarra”) Project. DNA was obtained from saliva and lifestyle and dietary data were 
collected by validated self-reported questionnaires. Genotyping was assessed by RT-
PCR plus allele discrimination.  
Subjects carrying the Ala allele of PPARG2 gene had a significantly increased obesity 
risk compared to non carrier -Pro12Pro- subjects (OR 1.66, 95% CI: 1.01-2.74, 
p=0.045). Greater obesity risk was also found in inactive or high carbohydrate intake 
subjects with the Ala12 allele of PPARG2 gene. Interestingly, subjects carrying the Ala 
allele of the PPARG2 gene and with a high CHO (>246 g/d) intake had an increased 
obesity risk compared to Pro12Pro subjects (OR 2.67, 95%CI: 1.3-5.46, p=0.007, p for 
[CHO xPPARG2] interaction=0.046). Moreover, in subjects with a high CHO intake the 
co-presence of the Ala allele of PPARG2 gene and one A minor allele (rs9939609) of 
FTO gene did increase obesity risk (OR 3.26, 95%CI: 1.19-8.89, p=0.021) when 
compared to non carrier (Pro12Pro/TT) subjects.  
In conclusion, it appears that lifestyle factors may act as effect modifiers for obesity risk 
linked to Ala12 allele of the PPARG2 gene and the A minor allele of FTO gene in an 
elderly population. 
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BACKGROUND 
Obesity is a complex disease with genetic and environmental basis (Marti 2008). FTO 
and PPARG2 gene variants for obesity risk have been widely studied (Razquin 2011). 
Several meta-analyses showed an increased BMI in subjects with the Ala allele of the 
PPARG2 gene (Masud 2003; Tonjes 2006). This observation was recently confirmed, 
carriers of the Ala allele of the PPARG2 gene had a significant higher BMI (+0.060 
kg/m
2
) compared to non-carriers (Galbete et al, in press), with a total of 49,337 subjects. 
As it is known the FTO gene harbours the stronger association with adiposity in GWAS 
studies. Although the physiological function of FTO remains unclear (Tung 2011). In 
the large meta-analysis of GWAS thus far performed with 123,865 individuals of 
European ancestry the FTO locus was confirmed as one of the 32 variants associated 
with BMI with P-values <5×10
−8
 (Speliotes 2010; Speakman 2011). A significant 
association between rs9939609 SNP of FTO gene and obesity, with an overall odds 
ratio (OR) for obesity of 1.31 under per-allele comparison was reported in another 
meta-analysis including 111,571 subjects (Peng 2011). 
Epidemiological studies have suggested that in addition to genetic factors, a variety of 
lifestyle factors (e.g., dietary composition, low level of physical activity (PA)) may 
contribute to the epidemic of obesity and interact with genetic factors to modify obesity 
risk (Chung 2008; Walley 2009).  
The interaction between lifestyle factors and these gene variants (Pro12Ala of PPARG2 
(rs1801282) and rs9939609 of FTO) have been explored in different populations and 
cohorts. On one hand, some studies have reported an interaction between Ala allele of 
PPARG2 gene variant and carbohydrate (CHO) or fat intake, (Marti 2002; Lamri 2011) 
on obesity risk whereas in others no association was found (Memisoglu 2003; Nelson 
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2007). A significant interaction between food intake and rs9939609 SNP of FTO gene 
on BMI was detected in some populations (Corella 2011; Lappalainen 2012; Moleres 
2012).  
With regard to PA, recently, Kilpelainen (2011) meta-analyzed data from 45 studies 
with a total of 218,166 adults. They reported a significant interaction between the minor 
A allele of rs9939609 and PA, being the odds for obesity risk 27% smaller in active vs. 
inactive subjects.   
A cohort study is the best way to identify incidence and natural history of a disease, and 
can be used to examine multiple outcomes after a single exposure (Grimes 2002). The 
SUN Project (Seguimiento Universidad de Navarra–University of Navarra Follow-up-)  
is a multi-purpose prospective Mediterranean dynamic cohort designed to study the 
prospective association of diet and other lifestyle factors with various health outcomes 
including cardiovascular disease, hypertension, diabetes or obesity (Martinez-Gonzalez 
2002; Segui-Gomez 2006). 
The aim of this study was to explore the effect of two gene variants, Pro12Ala of 
PPARG2 and rs9939609 of FTO, on obesity risk and to examine their interaction with 
lifestyle factors in an elderly population of the SUN study 
SUBJECTS AND METHODS 
Sample population 
This work has been conducted within the framework of the SUN Project (Martinez-
Gonzalez 2002). The SUN Project was initiated in December 1999 in Spain and 
recruitment is permanently open. All participants are university graduates and about 
50% of them are health professionals themselves.  
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Lifestyle and dietary data is collected by self-reported biennially mailed questionnaires 
(Alonso 2005; Bes-Rastrollo 2005; Martinez-Gonzalez 2005). Dietary intake was 
assessed using a semi-quantitative food frequency questionnaire (136 food items) 
included at baseline. Validity and reproducibility of this questionnaire has recently been 
re-evaluated (de la Fuente-Arrillaga 2010). Nutrient intakes of 136 food items were 
calculated as frequency multiplied by nutrient composition of specified portion size for 
each food item, using an ad hoc computer program developed for this purpose. A 
trained dietician updated the nutrient data bank using the latest available information 
from the food composition table for Spain. Baseline intake of macronutrients was 
analyzed as quantitative variables (grams per day) (de la Fuente-Arrillaga 2010; 
Fernandez-Ballart 2010).  
PA was ascertained through a baseline 17-item questionnaire. The index of metabolic 
equivalent task hours per week (METs-h/week) was computed by using the time spent 
engaging in 17 activities and multiplying the time spent by the resting metabolic rate 
(MET-score) specific for each activity. The METs-h/week for all activities were 
combined to obtain a value of total METs-h/week, which adequately correlated with the 
objectively measured energy expenditure in a validation study in a subsample of the 
cohort (Martinez-Gonzalez 2005). 
For this research, elderly participants of the SUN project (more than 55 years old when 
the baseline questionnaire was completed) were invited to participate in a genetic study 
in May 2008. Each participant received a kit designed to collect saliva and 1085 
participants agreed to participate but 986 kits were received back. Finally, 978 
volunteers were correctly genotyped for the rs1801282 SNP (PPARG2) and 967 for the 
rs9939609 SNP (FTO). The mean age was 69 years (70% male). Anthropometric data 
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was collected from the baseline questionnaire. Self-reported information on BMI had 
been previously validated in a subsample of the SUN Project (Bes-Rastrollo 2005). 
Specific written informed consent was requested to participate in this study. The study 
protocol was performed in accordance with the ethical standards of the Declaration of 
Helsinki (as revised in Hong Kong in 1989, in Edinburgh in 2000 and in South Korea in 
2008), and was approved by the Institutional Ethical Review Board of the University of 
Navarra.  
Genotyping 
Saliva samples were collected with specially designed kits (Oragene®ADN Self-
Collector kit-OG250) and DNA was extracted according to the manufacturer’s 
instructions. The genotyping for the Pro12Ala SNP of PPARG2 gene (rs1801282) and 
for the rs9939609 SNP of the FTO gene were performed using Taqman assays with 
allele-specific probes on the ABI Prism 7900HT Sequence Detection System (Applied 
Biosystems, Foster City, CA, USA) according to standardized laboratory protocols. 
Statistical analysis 
Hardy-Weinberg equilibrium was tested using a chi-square test. This test was also used 
to analyze if there were differences on the genotype distribution according to obesity 
status.  
The Odds Ratio (OR) for obesity associated with genotypes (dominant models) were 
fitted with an unconditional logistic regression model after adjustment for sex, age, PA 
and total energy intake as covariables. To address the combined effect of these two 
polymorphisms, Pro12Ala (rs1801282) of PPARG2 and rs9939609 of FTO gene 
(dominant model) a dummy variable was created. Non carrier subjects (Pro12Pro and 
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TT) were considered as the reference category. Three different categories according to 
the genotypes were considered: having the Ala allele (rs1801282) of PPARG2 gene, the 
A allele (rs9939609) of FTO gene, and the third, for the co-presence of the two risk 
alleles (Ala and A allele). The association between the different possible genotypes and 
BMI was analyzed using linear regression models and analysis of covariance 
(ANCOVA), after adjusting for potential confounders (sex, age, PA and total energy 
intake). We also evaluated the relationship between the genetic variants Pro12Ala 
(rs1801282) of PPARG2 and rs9939609 of FTO and a high CHO intake or low PA 
practice (dichotomized at the median) on obesity risk. Indicated interactions were 
estimated for obesity risk with the likelihood ratio test. Product terms between the SNPs 
and lifestyle factors were calculated firstly, with the corresponding variables 
dichotomized at the median (model 1 and 3), and secondly, as continuous variables 
(model 2 and 4). Interactions between the SNPs and lifestyle factors on BMI (as a 
continuous variable) were also tested. 
RESULTS 
Anthropometrical and lifestyle characteristics of elderly subjects of the SUN cohort 
according to the two genotypes (Pro12Ala SNP (rs1801282) of PPARG2 and the 
rs9939609 SNP of FTO gene, dominant model) are shown in Table 1. The frequencies 
of these two SNPs did fulfil the Hardy-Weinberg equilibrium.  
The ORs for obesity risk were calculated for each gene variant after adjustment for sex, 
age, PA and total energy intake. The presence of the Ala allele of PPARG2 gene 
significantly increased obesity risk in the adjusted models (including total population, 
subjects with high CHO intake, and those with low PA practice). The obesity risk linked 
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to the Ala12 allele of PPARG2 was 1.66 (95%CI: 1.01-2.74, p=0.045) in the total 
population (Table 2).  
Interestingly, as shown in Table 2, obesity risk was higher in subjects with a high CHO 
consumption (>246 g/day) carrying the Ala allele of the PPARG2 gene (OR 2.67, 
95%CI: 1.30-5.46, p=0.007). This p-value did remain statistically significant after 
applying the Benjamini-Hochberg multiple comparison correction. The interaction for 
obesity risk between CHO intake and PPARG2 gene was also statistically significant (p 
for [CHOxPPARG2] interaction =0.046). Similar results for this interaction were also 
obtained when considering CHO as a continuous trait (p for [CHOxPPARG2] 
interaction =0.030). 
Furthermore, subjects with a high CHO intake and carriers of the Ala allele, had an 
increased obesity risk, by the co-presence of one A minor allele (rs9939609) of FTO 
gene (OR 3.26, 95%CI: 1.19-8.89, p=0.021) compared to non carriers of the two alleles 
(Pro12Pro and TT) subjects with a high CHO intake. 
The presence of the Ala12 allele (rs1801282) of PPARG2 gene increased obesity risk to 
2.14 (95%CI: 1.13-4.05, p=0.020) in subjects with a sedentary lifestyle (<18.6 METs-
h/week) compared to Pro12Pro subjects. However, there was no evidence of statistical 
interaction (p for interaction = 0.243). Furthermore, in inactive carrier subjects of the 
Ala12 allele of PPARG2, the co-presence of the A minor allele (rs9939609) of FTO 
gene had a further rise in obesity risk to 2.51 (95%CI: 1.01-6.23, p=0.047) compared to 
inactive non carrier (Pro12Pro and TT) subjects. The interactions between the genetic 
variants and low PA practice for obesity risk were not statistically significant (Table 2).   
Linear regression models were also fitted to confirm the association between the co-
presence of the two risk alleles (Ala of the PPARG2 and A allele of FTO gene) and 
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BMI (as a continuous variable) in the three models undertaken: total population, high 
CHO intake and low PA practice (Table 2). Moreover, the same tendency was observed 
in the ANCOVA analysis (Figure 1).  
DISCUSSION 
The main finding of this work is that a high CHO consumption seems to modify the 
obesity risk linked to the Pro12Ala SNPs of the PPARG2 gene in an elderly population. 
Some strengths of the SUN cohort deserve to be mentioned. The homogeneity of 
participants with regard to socioeconomic status which helps to better control 
confounding and the higher educational level of participants in the cohort that ensures a 
higher validity in self-reported information (Beunza 2010; Sayon-Orea 2011). A 
potential limitation in our study is the self-reported outcome, nevertheless, self-reported 
weight and BMI had been previously validated (Bes-Rastrollo 2005). Another limitation 
is that identifying interactions between genetic variants and lifestyle factors may need 
much larger sample size (Smith 1984).  
The present work shows that the co-presence of these two risk alleles in PPARG2 and 
FTO gene increases obesity predisposition, but, novel studies are needed to elucidate 
the potential mechanisms. Pro12Ala variant of PPARG2 gene is one of the most studied 
genes as potentially linked to obesity phenotypes (Razquin 2011). Previous meta-
analysis had associated the Ala12 minor allele with a higher BMI (Masud 2003; Tonjes 
2006; Galbete et al. in press) and this study confirmed in a larger sample of aged subject 
the association of the Ala12 allele with obesity risk.  
Depending on the genotype the response of individuals to a dietary component or 
components could be different. The Pro12Ala genetic variant is probably the most 
studied mutation in relation to the interaction with dietary components on adiposity 
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features. Fatty acids are natural agonist of PPARG transcription factor; consequently 
most of the studies have been directed to analyze the interaction between Pro12Ala and 
fat intake. However, this study replicated an earlier association of this PPARG2 genetic 
variant with obesity risk linked to a high CHO intake (Marti 2002). Notably, in our 
study the interaction between CHO consumption and this Ala12 allele of PPARG2 for 
obesity risk was statistically significant although confirmation if needed in larger 
sample studies. 
The PPARG Pro12Ala genotype seems to be associated with obesity, type 2 diabetes 
and CHD risk (Dallongeville 2009). This variant is a diet-dependent sensor, and in the 
presence of a positive energy balance, the adipogenic capacity of the Ala allele exceeds 
that of the Pro12 genotype, being partially attributed to diet-dependent effects of the 
PPARG2 Pro12Ala genotype on adiponectin signaling and on the interaction of 
PPARG2 with several transcriptional coregulators (Anderson 2010). From a 
mechanistic point of view it is shown that the Ala12 allele alters ligand interaction 
between PPARG2 and its cofactors (Pgc1alfa, SRC1, Ncor) leading to an effect beyond 
decreased DNA binding efficiency (Heikkinen 2009) .The enhancement in obesity risk 
linked to a high CHO intake may be partly explained by the fact that CHO are not able 
to activate the PPARG protein and could worsen the action of the Ala12 substitution on 
the receptor activity.  
The impact of this rs9939609 SNP of FTO gene on human body weight is mainly 
through energy intake, however some results are contradictory (Berentzen 2008; Do 
2008; Speakman 2008, Goossens 2009; Haupt 2009). In our elderly population no effect 
of FTO on obesity was found. This observation agrees with former findings in mature 
subjects. Hardy (2010) described a weak association between FTO and BMI at age of 
50 years. Jacobsson (2011) suggested that the effect of FTO on corporal adiposity may 
11 
 
decrease by age. Our limited sample size could also impair our ability to find significant 
results.  
In regard to PA it is well known that there is an inverse relationship with obesity 
(Levine 1999; Levine 2005; Kuliczkowska 2008). Previous studies had reported that a 
high PA practice was linked to a lower fasting insulin level in Pro12 homozygous 
subjects of PPARG2 gene (Franks 2004) but no studies were found on association 
between Pro12Ala polymorphism and inactivity on obesity risk. Nevertheless, our 
results suggested an association of this genetic variant with obesity risk linked a low PA 
practice.  
To our knowledge we assessed for the first time the joint association of PPARG2 and 
FTO gene variants on obesity risk when modulated by lifestyle factors. Previous studies 
have found a higher obesity risk associated with the combined effect of several 
polymorphisms. Some research work reported the combined effect of PPARG and 
ADRB3 or ACE I/D gene variants for increasing BMI (Huang 2011; Passaro 2011) 
stated that the combined effect of FTO and MC4R genetic variants was strongly 
associated with obesity risk and BMI. Similarly, Cauchi (2009) observed that these two 
genetic variants increased obesity risk by 24% and low PA levels did accentuate this 
effect. Our study showed that the effect of PPARG2 (Ala12 allele) and FTO 
(rs9939609) gene variants on obesity effect might depend on high CHO intake. 
In summary, it seems that lifestyle factors may act as effect modifiers for obesity risk 
linked to Ala12 allele of the PPARG2 gene and the A minor allele of FTO gene in an 
elderly population. 
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FIGURE LEGEND 
Fig. 1 BMI differences according to genotype (dominant models for Pro12Ala and 
rs9939609 SNPs) for the three population groups (total population, only subjects with a 
high CHO intake or a low physical activity practice)   
Adjusted for sex, age, physical activity and total energy intake 
* 
p<0.05 between Ala12+TA/AA and Pro12Pro+TT genotypes  
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Table 1: Baseline characteristics according to genotype for elderly subjects from the SUN project. 
    PPRG2 rs1801282 
 
FTO rs9939609  
  Pro12Pro 
(n=814) 
Ala12 
(n=164) p-vaule
a
 
TT 
(n=336) 
TA/AA 
(n=631) p-vaule
a
 
% Male 70% 74% 0.275 72% 70% 0.657 
Age (years) 69 (6) 70 (7) 0.071 69 (6) 69 (6) 0.484 
BMI (kg/m
2
) 25.7 (3.2) 26.2 (3.2) 0.091 25.6 (3.1) 25.9 (3.2) 0.173 
Total Energy Intake (kcal/day) 2378 (903) 2484 (1021) 0.182 2412 (1038) 2384 (862) 0.654 
CHO intake (g/day) 267 (129) 281 (147) 0.200 272 (147) 267 (123) 0.647 
Protein intake (g/day) 107 (40) 109 (37) 0.686 109 (46) 107 (36) 0.449 
Fat intake (g/day) 91 (39) 93 (42) 0.392 91 (41) 91 (39) 0.883 
Physical activity (METs-h/week) 23.9 (20.7) 24.3 (21.5) 0.828 23.3 (20.1) 24.5 (21.3) 0.387 
Values are expressed as mean (SD), unless otherwise state 
a
 Continuous variables were compared using a Student-t test. Categorical variables were 
compared using chi squared test. 
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Table 2: Odds Ratios (OR) for obesity risk and linear regression coefficients for the association between the 
rs9939609 of FTO gene and Pro12Ala SNPs of the PPARG2 gene and BMI in elderly participants of the SUN 
project  
  
       OR (95% CI) 
       for obesity       p value p for interactiona B (95% CI)b p value 
p for 
interactionc 
PPARG2 (rs1801282)        
Pro12Pro  1 (ref)   0 (ref)    
Ala12  1.66 (1.01-2.74) 0.045  0.40 (-0.13-0.90)  0.139  
FTO (rs9939609)        
TT  1 (ref)   0 (ref)    
TA/AA  1.03 (0.66-1.60) 0.892  0.33 (-0.08-0.74)  0.112  
Genotype 
       FTO e            PPARG2 e     
 
 
 
- - 1 (ref)   0 (ref)    
- + 1.92 (0.86-4.27) 0.111  0.46 (-0.36-1.30)  0.287  
+ - 1.10 (0.66-1.84) 0.704  0.34 (-0.11-0.79)  0.135  
+ + 1.71 (0.84-3.48) 0.138  0.79  (0.08-1.50)  0.030  
  
High CHO intake (> 246 g/day) model 1/model 2 
PPARG2 (rs1801282)   0.046/0.030           0.260 
Pro12Pro  1 (ref)   0 (ref)    
Ala12  2.67 (1.30-5.46) 0.007d  0.49 (-0.21-1.20)  0.169  
FTO (rs9939609)   0.609/0.449           0.739 
TT  1 (ref)   0 (ref)    
TA/AA  1.15 (0.57-2.31) 0.697  0.46 (-0.11-1.03)  0.111  
Genotype 
       FTO e             PPARG2 e   0.814/0.844           0.973 
- - 1 (ref)   0 (ref)    
- + 1.92 (0.79-6.76) 0.312  0.28 (-0.03-1.43)  0.639  
+ - 1.04 (0.60-2.41) 0.924  0.41 (-0.22-1.03)  0.204  
+ + 3.26 (1.19-8.89) 0.021  1.07 (0.10-2-03)  0.031  
  
Low physical activity practice (< 18.6 METs-h/week) model 3/model 4 
PPARG2 (rs1801282)   0.266/0.243           0.741 
Pro12Pro  1 (ref)   0 (ref)    
Ala12  2.14 (1.13-4.05) 0.020  0.93 (0.16-1.69)  0.017d  
FTO (rs9939609)   0.366/0.152           0.417 
TT  1 (ref)   0 (ref)    
TA/AA  1.14 (0.64-2.06) 0.652  0.56 (-0.05-1.16)  0.070  
Genotype 
       FTO e             PPARG2 e   0.346/0.230           0.360 
- - 1 (ref)   0 (ref)    
- + 2.31 (0.79-6.76) 0.125  0.63 (-0.65-1.90)  0.334  
+ - 1.21 (0.60-2.41) 0.594  0.48 (-0.18-1.14)  0.156  
+ + 2.51 (1.01-6.23) 0.047  1.67 (0.63-2.71)  0.002d  
Adjusted for gender, age, physical activity and total energy intake 
 (a) p value for Likelihood Ratio Test for obesity risk. (b) Adjusted differences in average BMI (kg/m
2
) 
between genotypes. (c) p value for interaction for BMI (as continuous variable). (d) p value < 0.05 after 
correcting for Benjamini-Hochberg multiple comparisons. (e) (-) Non carriers of the minor risk alleles (+) 
Subjects carrying the minor risk alleles, either Pro12Ala of PPARG2 gene or rs9939609 of FTO gene. Model 
1: interaction term = genotype*CHO (dichotomized at the median); model 2: interaction term = 
genotype*CHO (continuous); model 3: interaction term = genotype*PA (dichotomized at the median); model 
4: interaction term = genotype*PA (continuous) 
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Figure 1: 
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